Treating Hyperuricemia: The Last Word Hasn't Been Said Yet
Elisa Russo1, Daniela Verzola1, Giovanna Leoncini1,2
1Department of Internal Medicine, University of Genova, Viale Benedetto XV, 6, 16132 Genova, Italy.
Urate-lowering treatments may not protect kidneys in chronic kidney disease. This review examines trials to understand why urate-lowering drugs might not improve kidney outcomes.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Rheumatology
Background:
- Gout and asymptomatic hyperuricemia are linked to cardiovascular disease and chronic kidney disease.
- Uric acid may cause kidney damage through hemodynamic and tissue toxicity.
- Recent trials question the renal benefits of urate-lowering treatments like allopurinol.
Purpose of the Study:
- To explore reasons for the ineffectiveness of urate-lowering treatment in chronic kidney disease progression.
- To critically review existing randomized controlled trials on urate-lowering agents and kidney outcomes.
Main Methods:
- Systematic review of randomized controlled trials (RCTs).
- Included trials compared urate-lowering agents with placebo or no medication for at least 12 months.
- Focused on renal clinical outcomes.
Main Results:
- Review of available RCTs comparing urate-lowering agents with placebo.
- Analysis of renal outcomes in patients with chronic kidney disease.
- Data synthesis to identify factors influencing treatment efficacy.
Conclusions:
- The efficacy of urate-lowering treatment in preventing chronic kidney disease progression requires further investigation.
- Understanding the mechanisms behind uric acid's renal toxicity is crucial.
- Clinical trial results challenge current assumptions about renal protection via urate reduction.
More Related Videos
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023
04:25Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases
Published on: November 8, 2024
Related Concept Videos
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Antihypertensive Drugs: Action of Diuretics
Urinary Tract Calculi V: Nursing Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Urinary Tract Calculi VI: Surgical Management
![Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F61682.jpg&w=3840&q=50)